Extracorporeal membrane oxygenation (ECMO) is a life-saving mechanical support technique used in patients with severe cardiogenic shock when conventional therapies fail. In cardiogenic shock, the heart is unable to pump sufficient blood to meet the body’s needs, leading to organ hypoperfusion. Veno-arterial (VA) ECMO provides both cardiac and respiratory support by diverting blood from the venous system, oxygenating it externally, and returning it to the arterial system. This reduces the workload on the heart, improves oxygen delivery, and stabilizes hemodynamics. ECMO serves as a bridge to recovery, decision-making, heart transplantation, or long-term mechanical circulatory support. Despite its benefits, ECMO carries risks such as bleeding, thrombosis, limb ischemia, and infection. Patient selection, timing of initiation, and multidisciplinary care are critical for optimal outcomes. While ECMO has improved survival in cardiogenic shock, ongoing research is focused on refining indications, minimizing complications, and enhancing long-term recovery strategies in critically ill patients.
Senior Consultant Critical Care Medicine Apollo Hospitals, Kolkata
Comments
Comments
You must be logged in to leave a comment.